MAPT and Parkinson disease: Increased phosphorylation of tau have been reported in multiple cellular and animal models expressing pathogenic LRRK2 mutants and in the postmortem brains from LRRK2-linked PD patients [39,86,87,88], although it is not clear whether the phosphorylation is directly mediated by LRRK2.